Contemporary Trends in Antiseptic Pocket Rinse in Primary Breast Implant Surgery.

This article examines contemporary trends in the use of antiseptic pocket rinse during primary breast implant surgery in Australia, based on data from the Australian Breast Device Registry (ABDR) collected between 2015 and 2020. Analysis of 37,178 patients (73,935 implants) revealed that 56.7% of implants were irrigated with antiseptic solutions aligned with the "14-point plan," primarily povidone-iodine (PVP-I) and Betadine triple antibiotic solution, while 32.8% received no antiseptic rinse. The study highlights variability in antiseptic rinse practices and aims to inform a subsequent large-scale retrospective cohort study to evaluate the clinical outcomes associated with PVP-I pocket irrigation. Limitations include inconsistent reporting of antiseptic concentrations and incomplete data from certain regions, but the registry's high capture rate supports the representativeness of the findings.